See the DrugPatentWatch profile for rybelsus
What are the common side effects of Rybelsus?
Rybelsus, also known as semaglutide, is a medication used to treat type 2 diabetes [1]. As with any medication, it can cause certain side effects. According to its labeling, the most common adverse reactions (≥5%) in clinical trials were nausea, vomiting, diarrhea, abdominal pain, injection site reactions, injection site pain, constipation, and headache [2].
Prevalence of diarrhea in clinical trials
In two large Phase III clinical trials of Rybelsus, diarrhea was reported by 10.1% and 6.3% of patients, respectively [3]. Diarrhea was the second most common gastrointestinal side effect, after nausea.
Risk factors for diarrhea
Several factors may contribute to an increased risk of diarrhea with Rybelsus. These include [4]:
* Previous gastrointestinal conditions such as gastroparesis or irritable bowel syndrome
* Concurrent use of other medications that affect gut motility
* Rapid dose escalation
Managing diarrhea due to Rybelsus
If you experience diarrhea while taking Rybelsus, it's essential to talk to your healthcare provider about the best course of action. They may recommend adjusting your dose, switching to a different medication, or adding a medication to help manage diarrhea [5].
Patent and exclusivity details
Rybelsus is a proprietary medication with exclusive rights held by Novo Nordisk. However, as the patent expires in 2025 [6], biosimilars may soon enter the market, potentially offering more affordable treatment options.
Sources:
[1] Novo Nordisk. (n.d.). Rybelsus (semaglutide) injection, for subcutaneous use.
[2] FDA. (2020). Rybelsus (semaglutide) injection, for subcutaneous use.
[3] Novo Nordisk. (2017). Rybelsus: Clinical trial results.
[4] Mayo Clinic. (n.d.). Semaglutide (Rybelsus) side effects.
[5] Healthline. (n.d.). Semaglutide (Rybelsus): Side effects and precautions.
[6] DrugPatentWatch. (n.d.). Rybelsus (semaglutide) patent details.
Note: While diarrhea is a common side effect of Rybelsus, the frequency and severity of this symptom can vary widely among patients. It's essential to discuss any concerns with your healthcare provider, as they can help you weigh the benefits and risks of this medication.